TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 44 filers reported holding TOKAI PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $31,000 | -13.9% | 36,569 | 0.0% | 0.00% | – |
| Q4 2016 | $36,000 | -36.8% | 36,569 | -2.4% | 0.00% | – |
| Q3 2016 | $57,000 | -72.3% | 37,473 | 0.0% | 0.00% | – |
| Q2 2016 | $206,000 | +7.9% | 37,473 | +10.2% | 0.00% | – |
| Q1 2016 | $191,000 | -35.7% | 34,017 | 0.0% | 0.00% | – |
| Q4 2015 | $297,000 | -15.6% | 34,017 | 0.0% | 0.00% | – |
| Q3 2015 | $352,000 | +35.9% | 34,017 | +75.0% | 0.00% | – |
| Q2 2015 | $259,000 | +8.8% | 19,437 | -7.9% | 0.00% | – |
| Q1 2015 | $238,000 | -23.5% | 21,101 | 0.0% | 0.00% | – |
| Q4 2014 | $311,000 | – | 21,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 637,110 | $3,574,187,000 | 0.71% |
| Novo Holdings A/S | 470,946 | $2,642,000 | 0.29% |
| Perceptive Advisors | 485,338 | $2,723,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 812,200 | $4,556,000 | 0.23% |
| FNY Managed Accounts LLC | 6,438 | $36,117,000 | 0.06% |
| NJ State Employees Deferred Compensation Plan | 35,000 | $271,000 | 0.06% |
| Alyeska Investment Group, L.P. | 315,757 | $1,771,000 | 0.02% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $34,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $337,000 | 0.01% |
| BlackRock Fund Advisors | 530,538 | $2,976,000 | 0.00% |